Zobrazeno 1 - 10
of 85
pro vyhledávání: '"59"'
Autor:
Kang-Yi Su, Kun-Chieh Chen, Gee-Chen Chang, Kuo-Hsuan Hsu, Tsung-Ying Yang, Jeng-Sen Tseng, Yen-Hsiang Huang, Sung-Liang Yu
Publikováno v:
Scientific Reports
It remains unclear how programmed death-ligand 1 (PD-L1) expression interacts with anaplastic lymphoma kinase (ALK) mutation, its variants, and the outcome of treatment. One hundred and twenty four out of 1255 patients (9.9%) were deemed ALK-positive
Autor:
Daria S. Chulpanova, Ekaterina Garanina, Svetlana F. Khaiboullina, Marina O. Gomzikova, Elvira R. Akhmetzyanova, Svetlana S. Arkhipova, Valeriya V. Solovyeva, Victoria James, Albert A. Rizvanov, Leysan G. Tazetdinova
Publikováno v:
Bioengineering
Volume 7
Issue 2
Bioengineering, Vol 7, Iss 59, p 59 (2020)
Volume 7
Issue 2
Bioengineering, Vol 7, Iss 59, p 59 (2020)
High-dose recombinant interleukin 2 (IL2) therapy has been shown to be successful in renal cell carcinoma and metastatic melanoma. However, systemic administration of high doses of IL2 can be toxic, causing capillary leakage syndrome and stimulating
Autor:
Xavier Troussard, Agnès Olivrie, Gandhi Damaj, Stephanie Noel, Jean-Claude Eisenmann, Olivier Hermine, Jérémie Riou, Sandrine Vaudaux, Patricia Validire-Charpy, Jean Gutnecht, Alain Devidas, Charlotte Petitdidier-Lionnet, Mohamed Touati, Stephanie Haiat, Vincent Levy, Fabienne Huysman, Eric Lippert, Aline Tanguy-Schmidt, Jehan Dupuis, Olivier Lambotte, Clara Mariette, Marouane Boubaya, Edouard Cornet, Pierre Feugier, Mathilde Hunault-Berger, Bertrand Joly, Stéphane Leprêtre, Jérôme Paillassa, Cécile Tomowiak, Kamel Ghomari, Willy Vaillant, Catherine Thieblemont, Mario Ojeda Uribe, Didier Decaudin, Bernard Drenou, Jean-Michel Karsenti
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Nature Publishing Group, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-12 (2020)
Blood Cancer Journal, Nature Publishing Group, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, 2020, 10 (5), pp.62. ⟨10.1038/s41408-020-0328-z⟩
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-12 (2020)
In total, 279 patients with hairy-cell leukemia (HCL) were analyzed, with a median follow-up of 10 years. Data were collected up to June 2018. We analyzed responses to treatment, relapses, survival, and the occurrence of second malignancies during fo
Autor:
Celina Ledesma, Roy B. Jones, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Borje S. Andersson, Krina K. Patel, Sairah Ahmed, Stefan O. Ciurea, Qaiser Bashir, Amin M. Alousi, Genevieve Lyons, Betul Oran, Uday R. Popat, Amanda Olson, Elizabeth J. Shpall, Roland L. Bassett, Gabriela Rondon, Nina Shah, David Marin, Muzaffar H. Qazilbash, Richard E. Champlin, Ben C. Valdez, Yago Nieto, Katayoun Rezvani
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:285-292
We investigated the long-term safety and disease control data obtained with i.v. busulfan (Bu) combined with clofarabine (Clo) in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem cell transplantation (HSCT). A
Autor:
Peter J. Frederick, J. Brian Szender, Kunle Odunsi, K.S. Grzankowski, Shashikant Lele, Chandra L. Spring-Robinson
Publikováno v:
International Journal of Gynecologic Cancer. 26:1440-1447
BackgroundThe time interval between diagnoses of breast cancer (BC) and endometrial cancer (EC) is not well established in women with metachronous primary tumors. We sought to examine this interval and identify associations with treatment-related and
Autor:
Anna Maria Storniolo, Aditya Bardia, Cesar A. Santa-Maria, Vered Stearns, Claire F. Snyder, Antonio C. Wolff, Stacie Jeter, Anne Nguyen, Shannon Slater, Daniel F. Hayes, John H. Fetting, Katie Quinlan, Robert S. Miller, Roisin M. Connolly, Nora Lynn Henry, Gary L. Rosner, Jane Zorzi, Amanda L. Blackford
Publikováno v:
Breast cancer research and treatment. 171(1)
PURPOSE: Aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) are common adverse events of AIs often leading to drug discontinuation. We initiated a prospective clinical trial to evaluate whether bisphosphonates are associated with reduced
Autor:
Deborah Kuk, Karin Avila, Michael F. Berger, Raphael Pelossof, Martin R. Weiser, Sujata Patil, Julio Garcia-Aguilar, J. Joshua Smith, Niedzica Camacho, Metin Keskin, Emily K. Bergsland, Chin-Tung Chen, Zhenbin Chen, Oliver S. Chow
Publikováno v:
Annals of surgical oncology, vol 23, iss 8
BackgroundThe response of rectal cancers to neoadjuvant chemoradiation (CRT) is variable, but tools to predict response remain lacking. We evaluated whether KRAS and TP53 mutations are associated with pathologic complete response (pCR) and lymph node
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeabc9fb98402484094912f5864f159f
https://escholarship.org/uc/item/3996d32n
https://escholarship.org/uc/item/3996d32n
Autor:
Claude Eric Bulabois, Nicole Raus, Anne Huynh, Valerie Rolland, Marie Hélène Schlageter, Brigitte Dupriez, Jean-Jacques Kiladjian, Edouard Forcade, David Michonneau, Stéphanie N. Guyen, Alban Villate, Fiorenza Barraco, Raphaël Porcher, Felipe Suarez, Bruno Cassinat, Amandine Charbonnier, Françoise Boyer, Jacques-Olivier Bay, Gérard Socié, Jérôme Cornillon, Sylvain Chantepie, Ibrahim Yakoub-Agha, Laure Vincent, Pascal Turlure, Marie Robin, Corentin Orvain, Marie Y Detrait
Publikováno v:
Bone Marrow Transplantation
This multicenter prospective phase 2 trial analyzed disease-free survival (DFS) in myelofibrosis patients receiving ruxolitinib for 6 months before transplantation. Seventy-six patients were recruited. Age-adjusted dynamic international prognostic sc
Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention
Autor:
Robert, Benamouzig, Bernard, Uzzan, Antoine, Martin, Jacques, Deyra, Julian, Little, Bernard, Girard, Stanislas, Chaussade, J, Esteve
Publikováno v:
Gut
Gut, 2010, 59 (5), pp.622-629. ⟨10.1136/gut.2008.175406⟩
Gut, 2010, 59 (5), pp.622-629. ⟨10.1136/gut.2008.175406⟩
International audience; Background Low-dose aspirin reduces the incidence of colorectal cancer and recurrence of adenomas. Cyclooxygenase-2 (COX-2), one of its main target enzymes, is reportedly over-expressed in colorectal adenomas.Aim To assess COX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cd87511cbecb58118205519d8c755e
https://hal.univ-angers.fr/hal-03388315
https://hal.univ-angers.fr/hal-03388315
Autor:
Lajos Pusztai, Tao Qing, Courtney Frederick, Julia Foldi, Kerin B. Adelson, Nina R. Horowitz, Trisha Burrello, Michal Marczyk, Emily Reisenbichler, Kim Blenman, Anees B. Chagpar, Anamika Katoch, Tristen S. Park, Kamaljeet Singh, David L. Rimm, Neal A. Fischbach, Justin Persico, Yalai Bai, Andrea Silber, Donald R. Lannin, Eiman Y Ibrahim
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-7 (2021)
NPJ Breast Cancer
NPJ Breast Cancer
The goal of this Phase I/II trial is to assess the safety and efficacy of administering durvalumab concurrent with weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide (ddAC) neoadjuvant therapy for stages I–III triple-negative breast